ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Travelers Vaccines Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-31J13966
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Travelers Vaccines Market Research Report 2023
BUY CHAPTERS

Global Travelers Vaccines Market Research Report 2026

Code: QYRE-Auto-31J13966
Report
2026-01-26
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi Pasteur
Merck
Pfizer Inc
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

Travelers Vaccines Market Size

The global Travelers Vaccines market was valued at US$ 4291 million in 2025 and is anticipated to reach US$ 7682 million by 2032, at a CAGR of 8.8% from 2026 to 2032.

Travelers Vaccines Market

Travelers Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Travelers Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report delivers a comprehensive overview of the global Travelers Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Travelers Vaccines. The Travelers Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Travelers Vaccines market comprehensively. Regional market sizes by Type, by End Users, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Travelers Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End Users, and by region.
Market Segmentation

Scope of Travelers Vaccines Market Report

Report Metric Details
Report Name Travelers Vaccines Market
Accounted market size in 2025 US$ 4291 million
Forecasted market size in 2032 US$ 7682 million
CAGR 8.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other
by End Users
  • Tourists
  • Students
  • Workers
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End Users, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Travelers Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Travelers Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by End Users, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Travelers Vaccines Market growing?

Ans: The Travelers Vaccines Market witnessing a CAGR of 8.8% during the forecast period 2026-2032.

What is the Travelers Vaccines Market size in 2032?

Ans: The Travelers Vaccines Market size in 2032 will be US$ 7682 million.

What is the Merck, GlaxoSmithKline, Sanofi Pasteur share in Travelers Vaccines Market?

Ans: Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration.

What is the Travelers Vaccines Market share by region?

Ans: North America and Europe are the main production regions, with market share of more than 40% and 30%.

Who are the main players in the Travelers Vaccines Market report?

Ans: The main players in the Travelers Vaccines Market are GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai

What are the Type segmentation covered in the Travelers Vaccines Market report?

Ans: The Types covered in the Travelers Vaccines Market report are Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other

What are the End User segmentation covered in the Travelers Vaccines Market report?

Ans: The End users covered in the Travelers Vaccines Market report are Tourists, Students, Workers, Others

1 Travelers Vaccines Market Overview
1.1 Product Definition
1.2 Travelers Vaccines by Type
1.2.1 Global Travelers Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Travelers Vaccines by End Users
1.3.1 Global Travelers Vaccines Market Value by End Users: 2025 vs 2032
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Global Travelers Vaccines Market Size Estimates and Forecasts
1.4.1 Global Travelers Vaccines Revenue 2021–2032
1.4.2 Global Travelers Vaccines Sales 2021–2032
1.4.3 Global Travelers Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Travelers Vaccines Market Competition by Manufacturers
2.1 Global Travelers Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Travelers Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Travelers Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Travelers Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Travelers Vaccines, Date of Entry into the Industry
2.8 Global Travelers Vaccines Market Competitive Situation and Trends
2.8.1 Global Travelers Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Travelers Vaccines Players Market Share by Revenue
2.8.3 Global Travelers Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Travelers Vaccines Market Scenario by Region
3.1 Global Travelers Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Travelers Vaccines Sales by Region: 2021–2032
3.2.1 Global Travelers Vaccines Sales by Region: 2021–2026
3.2.2 Global Travelers Vaccines Sales by Region: 2027–2032
3.3 Global Travelers Vaccines Revenue by Region: 2021–2032
3.3.1 Global Travelers Vaccines Revenue by Region: 2021–2026
3.3.2 Global Travelers Vaccines Revenue by Region: 2027–2032
3.4 North America Travelers Vaccines Market Facts & Figures by Country
3.4.1 North America Travelers Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Travelers Vaccines Sales by Country (2021–2032)
3.4.3 North America Travelers Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Travelers Vaccines Market Facts & Figures by Country
3.5.1 Europe Travelers Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Travelers Vaccines Sales by Country (2021–2032)
3.5.3 Europe Travelers Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Travelers Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Travelers Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Travelers Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Travelers Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Travelers Vaccines Market Facts & Figures by Country
3.7.1 Latin America Travelers Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Travelers Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Travelers Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Travelers Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Travelers Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Travelers Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Travelers Vaccines Sales by Type (2021–2032)
4.1.1 Global Travelers Vaccines Sales by Type (2021–2026)
4.1.2 Global Travelers Vaccines Sales by Type (2027–2032)
4.1.3 Global Travelers Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Travelers Vaccines Revenue by Type (2021–2032)
4.2.1 Global Travelers Vaccines Revenue by Type (2021–2026)
4.2.2 Global Travelers Vaccines Revenue by Type (2027–2032)
4.2.3 Global Travelers Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Travelers Vaccines Price by Type (2021–2032)
5 Segment by End Users
5.1 Global Travelers Vaccines Sales by End Users (2021–2032)
5.1.1 Global Travelers Vaccines Sales by End Users (2021–2026)
5.1.2 Global Travelers Vaccines Sales by End Users (2027–2032)
5.1.3 Global Travelers Vaccines Sales Market Share by End Users (2021–2032)
5.2 Global Travelers Vaccines Revenue by End Users (2021–2032)
5.2.1 Global Travelers Vaccines Revenue by End Users (2021–2026)
5.2.2 Global Travelers Vaccines Revenue by End Users (2027–2032)
5.2.3 Global Travelers Vaccines Revenue Market Share by End Users (2021–2032)
5.3 Global Travelers Vaccines Price by End Users (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Travelers Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfizer Travelers Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Company Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CNBG Travelers Vaccines Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Sanofi Pasteur MSD
6.6.1 Sanofi Pasteur MSD Company Information
6.6.2 Sanofi Pasteur MSD Description and Business Overview
6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
6.7 Serum Institute of India
6.7.1 Serum Institute of India Company Information
6.7.2 Serum Institute of India Description and Business Overview
6.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Biokangtai
6.8.1 Biokangtai Company Information
6.8.2 Biokangtai Description and Business Overview
6.8.3 Biokangtai Travelers Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biokangtai Travelers Vaccines Product Portfolio
6.8.5 Biokangtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Travelers Vaccines Industry Chain Analysis
7.2 Travelers Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Travelers Vaccines Production Mode & Process Analysis
7.4 Travelers Vaccines Sales and Marketing
7.4.1 Travelers Vaccines Sales Channels
7.4.2 Travelers Vaccines Distributors
7.5 Travelers Vaccines Customer Analysis
8 Travelers Vaccines Market Dynamics
8.1 Travelers Vaccines Industry Trends
8.2 Travelers Vaccines Market Drivers
8.3 Travelers Vaccines Market Challenges
8.4 Travelers Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi Pasteur
Merck
Pfizer Inc
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
List of Tables
 Table 1. Global Travelers Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Travelers Vaccines Market Value by End Users (US$ Million), 2025 vs 2032
 Table 3. Global Travelers Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Travelers Vaccines Sales (K Doses) of Key Manufacturers (2021–2026)
 Table 5. Global Travelers Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Travelers Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Travelers Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Travelers Vaccines Average Price (USD/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Travelers Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Travelers Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Travelers Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Travelers Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Travelers Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Travelers Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Travelers Vaccines Sales by Region (K Doses), 2021–2026
 Table 18. Global Travelers Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Travelers Vaccines Sales by Region (K Doses), 2027–2032
 Table 20. Global Travelers Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Travelers Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Travelers Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Travelers Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Travelers Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Travelers Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Travelers Vaccines Sales by Country (K Doses), 2021–2026
 Table 27. North America Travelers Vaccines Sales by Country (K Doses), 2027–2032
 Table 28. North America Travelers Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Travelers Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Travelers Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Travelers Vaccines Sales by Country (K Doses), 2021–2026
 Table 32. Europe Travelers Vaccines Sales by Country (K Doses), 2027–2032
 Table 33. Europe Travelers Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Travelers Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Travelers Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Travelers Vaccines Sales by Region (K Doses), 2021–2026
 Table 37. Asia Pacific Travelers Vaccines Sales by Region (K Doses), 2027–2032
 Table 38. Asia Pacific Travelers Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Travelers Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Travelers Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Travelers Vaccines Sales by Country (K Doses), 2021–2026
 Table 42. Latin America Travelers Vaccines Sales by Country (K Doses), 2027–2032
 Table 43. Latin America Travelers Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Travelers Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Travelers Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Travelers Vaccines Sales by Country (K Doses), 2021–2026
 Table 47. Middle East and Africa Travelers Vaccines Sales by Country (K Doses), 2027–2032
 Table 48. Middle East and Africa Travelers Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Travelers Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Travelers Vaccines Sales (K Doses) by Type (2021–2026)
 Table 51. Global Travelers Vaccines Sales (K Doses) by Type (2027–2032)
 Table 52. Global Travelers Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Travelers Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Travelers Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Travelers Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Travelers Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Travelers Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Travelers Vaccines Price (USD/Dose) by Type (2021–2026)
 Table 59. Global Travelers Vaccines Price (USD/Dose) by Type (2027–2032)
 Table 60. Global Travelers Vaccines Sales (K Doses) by End Users (2021–2026)
 Table 61. Global Travelers Vaccines Sales (K Doses) by End Users (2027–2032)
 Table 62. Global Travelers Vaccines Sales Market Share by End Users (2021–2026)
 Table 63. Global Travelers Vaccines Sales Market Share by End Users (2027–2032)
 Table 64. Global Travelers Vaccines Revenue (US$ Million) by End Users (2021–2026)
 Table 65. Global Travelers Vaccines Revenue (US$ Million) by End Users (2027–2032)
 Table 66. Global Travelers Vaccines Revenue Market Share by End Users (2021–2026)
 Table 67. Global Travelers Vaccines Revenue Market Share by End Users (2027–2032)
 Table 68. Global Travelers Vaccines Price (USD/Dose) by End Users (2021–2026)
 Table 69. Global Travelers Vaccines Price (USD/Dose) by End Users (2027–2032)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 73. GlaxoSmithKline Travelers Vaccines Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 78. Sanofi Pasteur Travelers Vaccines Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 83. Merck Travelers Vaccines Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 88. Pfizer Travelers Vaccines Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. CNBG Company Information
 Table 91. CNBG Description and Business Overview
 Table 92. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 93. CNBG Travelers Vaccines Product
 Table 94. CNBG Recent Developments/Updates
 Table 95. Sanofi Pasteur MSD Company Information
 Table 96. Sanofi Pasteur MSD Description and Business Overview
 Table 97. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 98. Sanofi Pasteur MSD Travelers Vaccines Product
 Table 99. Sanofi Pasteur MSD Recent Developments/Updates
 Table 100. Serum Institute of India Company Information
 Table 101. Serum Institute of India Description and Business Overview
 Table 102. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 103. Serum Institute of India Travelers Vaccines Product
 Table 104. Serum Institute of India Recent Developments/Updates
 Table 105. Biokangtai Company Information
 Table 106. Biokangtai Description and Business Overview
 Table 107. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)
 Table 108. Biokangtai Travelers Vaccines Product
 Table 109. Biokangtai Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Travelers Vaccines Distributors List
 Table 113. Travelers Vaccines Customers List
 Table 114. Travelers Vaccines Market Trends
 Table 115. Travelers Vaccines Market Drivers
 Table 116. Travelers Vaccines Market Challenges
 Table 117. Travelers Vaccines Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Travelers Vaccines
 Figure 2. Global Travelers Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Travelers Vaccines Market Share by Type: 2025 & 2032
 Figure 4. Meningococcal Vaccine Product Picture
 Figure 5. Japanese Encephalitis Vaccine Product Picture
 Figure 6. Yellow Fever Vaccine Product Picture
 Figure 7. Hepatitis Vaccine Product Picture
 Figure 8. Cholera Vaccine Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Travelers Vaccines Market Value by End Users (US$ Million), 2021–2032
 Figure 11. Global Travelers Vaccines Market Share by End Users: 2025 & 2032
 Figure 12. Tourists
 Figure 13. Students
 Figure 14. Workers
 Figure 15. Others
 Figure 16. Global Travelers Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Travelers Vaccines Market Size (US$ Million), 2021–2032
 Figure 18. Global Travelers Vaccines Sales (K Doses), 2021–2032
 Figure 19. Global Travelers Vaccines Average Price (USD/Dose), 2021–2032
 Figure 20. Travelers Vaccines Report Years Considered
 Figure 21. Travelers Vaccines Sales Share by Manufacturers in 2025
 Figure 22. Global Travelers Vaccines Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Travelers Vaccines Players: Market Share by Revenue in Travelers Vaccines in 2025
 Figure 24. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Travelers Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Travelers Vaccines Sales Market Share by Country (2021–2032)
 Figure 27. North America Travelers Vaccines Revenue Market Share by Country (2021–2032)
 Figure 28. U.S. Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Travelers Vaccines Sales Market Share by Country (2021–2032)
 Figure 31. Europe Travelers Vaccines Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Travelers Vaccines Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Travelers Vaccines Revenue Market Share by Region (2021–2032)
 Figure 39. China Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Taiwan Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Indonesia Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Thailand Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Malaysia Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Philippines Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Latin America Travelers Vaccines Sales Market Share by Country (2021–2032)
 Figure 50. Latin America Travelers Vaccines Revenue Market Share by Country (2021–2032)
 Figure 51. Mexico Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Brazil Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Argentina Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Middle East and Africa Travelers Vaccines Sales Market Share by Country (2021–2032)
 Figure 55. Middle East and Africa Travelers Vaccines Revenue Market Share by Country (2021–2032)
 Figure 56. Turkey Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Saudi Arabia Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. U.A.E Travelers Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Global Sales Market Share of Travelers Vaccines by Type (2021–2032)
 Figure 60. Global Revenue Market Share of Travelers Vaccines by Type (2021–2032)
 Figure 61. Global Travelers Vaccines Price (USD/Dose) by Type (2021–2032)
 Figure 62. Global Sales Market Share of Travelers Vaccines by End Users (2021–2032)
 Figure 63. Global Revenue Market Share of Travelers Vaccines by End Users (2021–2032)
 Figure 64. Global Travelers Vaccines Price (USD/Dose) by End Users (2021–2032)
 Figure 65. Travelers Vaccines Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Travelers Vaccination Market Research Report 2025
Global Human Vaccination Market Research Report 2025
Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Dog Vaccines Market Insights Forecast to 2030
Global Cat Vaccines Market Insights Forecast to 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Veterinary Vaccination Market Research Report 2025
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Animal Vaccines Market Research Report 2024
Global Biological Vaccines Adjuvants Market Research Report 2025
Veterinary Vaccine Market
Veterinary Vaccine Adjuvants Market
Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Conjugate Market Research Report 2025
Global Livestock Animal Vaccination Market Research Report 2025
Global Swine Vaccines Market Insights Forecast to 2030
Global Bacterial Vaccines for Humans Market Research Report 2024
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Vaccine Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions